Cyclacel Pharmaceuticals, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Cyclacel Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was -1.89K %, a 1009% decline year-over-year.
  • Cyclacel Pharmaceuticals, Inc. annual Return On Equity for 2023 was -407 %, a 389% decline from 2022.
  • Cyclacel Pharmaceuticals, Inc. annual Return On Equity for 2022 was -83.3 %, a 92.4% decline from 2021.
  • Cyclacel Pharmaceuticals, Inc. annual Return On Equity for 2021 was -43.3 %, a 21.3% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -407 -324 -389% Jan 1, 2023 Dec 31, 2023
2022 -83.3 -40 -92.4% Jan 1, 2022 Dec 31, 2022
2021 -43.3 -7.6 -21.3% Jan 1, 2021 Dec 31, 2021
2020 -35.7 +17.6 +33% Jan 1, 2020 Dec 31, 2020
2019 -53.2 -12.1 -29.4% Jan 1, 2019 Dec 31, 2019
2018 -41.1 +1.76 +4.1% Jan 1, 2018 Dec 31, 2018
2017 -42.9 +35.4 +45.2% Jan 1, 2017 Dec 31, 2017
2016 -78.3 -15.6 -24.9% Jan 1, 2016 Dec 31, 2016
2015 -62.7 +14.2 +18.5% Jan 1, 2015 Dec 31, 2015
2014 -76.9 -35.5 -85.8% Jan 1, 2014 Dec 31, 2014
2013 -41.4 +51.4 +55.4% Jan 1, 2013 Dec 31, 2013
2012 -92.8 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.